Advertisement

Itepekimab Bests Placebo for Moderate-to-Severe Asthma

0

Incidence of events indicating loss of asthma control lower with itepekimab monotherapy in phase 2, proof-of-concept trial

USPSTF Presents New Approach to Sex, Gender in Recommendations

0

Task force will use inclusive approach to identify issues related to sex, gender in guideline development; will use gender-neutral language

Pharmacies Often Not Notified of Discontinued Rx

0

Interventions, including phoning pharmacies and enabling CancelRX in electronic medical records, may reduce risk for medication safety events

Vaccines Effective in Preventing Symptomatic COVID-19 in Health Care Workers

0

Findings seen even for those at risk for severe disease and racial and ethnic groups disproportionately affected by the pandemic

Asthma, Smoking, Chronic Sinusitis Tied to Early COPD Risk

0

Large study of Hispanic adults shows association with risk for chronic obstructive pulmonary disease before age 50

EPA to Sharply Limit Refrigerant Production in New Climate Rule

0

Alternatives to HFCs and energy-efficient cooling technologies will save $270 billion and benefit public health during the next 30 years

Overweight Children With Asthma Less Likely to Respond to Treatment

0

Higher body mass index tied to poor response to inhaled corticosteroids

Many With Food Allergy Unaware of Oral Immunotherapy Option

0

Awareness disproportionately higher among wealthier, more highly educated respondents

Precedent Needed for FDA Approval Decisions When Evidence Lacking

0

In seven of 22 cases, approval used new interpretations of original evidence and did not require new evidence

Americans Struggling With High Cost of Prescription Drugs

0

Adults younger than 65 years twice as likely to report not filling needed prescriptions due to cost versus seniors